QID 376816

Date Published: 2022-08-10

QID 376816: Adobe FrameMaker Multiple Vulnerabilities (APSB22-42)

Adobe FrameMaker is a document processor designed for writing and editing large or complex documents, including structured documents.

CVE-2022-34264: Memory leak due to Out-of-bounds Read Vulnerability.
CVE-2022-35673: Arbitrary Code Execution due to Out-of-bounds Read Vulnerability.
CVE-2022-35674: Arbitrary Code Execution due to Out-of-bounds Read Vulnerability.
CVE-2022-35675: Arbitrary Code Execution due to Use After Free Vulnerability.
CVE-2022-35676: Arbitrary Code Execution due to Heap-based Buffer Overflow Vulnerability.
CVE-2022-35677: Arbitrary Code Execution due to Heap-based Buffer Overflow Vulnerability.
Affected Versions:
Adobe FrameMaker 2019 Release Update 8 and earlier
Adobe FrameMaker 2020 Release Update 4 and earlier. QID Detection Logic:(Authenticated)
This QID detects file versions of Adobe FrameMaker (FrameMaker.exe).

Successful exploitation of these vulnerabilities may allow an attacker to either execute arbitrary or memory leak of the target system.

CVSS V3 rated as High - 7.8 severity.

CVSS V2 rated as Medium - 4.6 severity.

Solution

Customers are advised to update to latest available version of adobe framemaker. Please visit APSB22-27 for more details.

Vendor References

APSB22-42 - helpx.adobe.com/security/products/framemaker/apsb22-42.html

CVEs related to QID 376816

CVE-2022-34264 | CVE-2022-35673 | CVE-2022-35674 | CVE-2022-35675 | CVE-2022-35676 | CVE-2022-35677 |

Software Advisories

Advisory ID	Software	Component	Link
APSB22-42			helpx.adobe.com/security/products/framemaker/apsb22-42.html

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].